Special Drug Use-results Survey for Long-term Use（Avacopan）

Launched by KISSEI PHARMACEUTICAL CO., LTD. · Dec 26, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the long-term use of a drug called avacopan for patients in Japan who have two specific conditions: microscopic polyangiitis (MPA) or granulomatosis with polyangiitis (GPA). The main goal of the study is to understand how safe and effective avacopan is when taken over an extended period. The trial is currently recruiting participants of all ages and genders who are already being treated with avacopan for these conditions.

If you or someone you know has MPA or GPA and is using avacopan, you might be eligible to participate in this survey. Participants will be asked about their experiences with the medication, which will help researchers gather important information on its long-term effects. This trial is significant because it aims to improve the understanding of avacopan's benefits and any potential risks over time, ultimately helping to enhance treatment options for patients with these conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan